Article

RGP lenses help restore vision in patients with corneal ectasia after LASIK

Rigid gas permeable (RGP) contact lenses can be used to restore functional vision in patients who have developed corneal ectasia after LASIK and to postpone penetrating keratoplasty, according to Maria Woodward, MD, Emory Eye Center, Atlanta

Rigid gas permeable (RGP) contact lenses can be used to restore functional vision in patients who have developed corneal ectasia after LASIK and to postpone penetrating keratoplasty, according to Maria Woodward, MD, Emory Eye Center, Atlanta.

In a retrospective review, Dr. Woodward and colleagues analyzed the visual outcomes of patients who had developed corneal ectasia after LASIK and then were treated with either RGP lenses, intracorneal ring segments (Intacs, Addition Technology), collagen crosslinking, or penetrating keratoplasty.

"The majority of patients (76%) who were treated with RGP lenses had good long-term success," Dr. Woodward reported. "Of those that could no longer wear RGP lenses (24%), three eyes received intracorneal ring segments, two eyes were treated with corneal crosslinking, and six eyes eventually had penetrating keratoplasty (PK)."

The final best-corrected visual acuity (BCVA) was 20/40 or better in 70% of the patients and 20/60 or better in 90%. Those who had PK had a final BCVA ranging up to 20/300.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.